{"nct_id":"NCT00594126","title":"Safety and Dose Study of GRN163L Administered to Treat Patients With Refractory or Relapsed Multiple Myeloma","status":"COMPLETED","status_verified_date":"2015-12","start_date":"2007-11","start_date_type":null,"primary_completion_date":"2011-07","primary_completion_date_type":"ACTUAL","completion_date":"2011-07","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GERN"]}